Open Access
Open access
Molecules, volume 26, issue 18, pages 5705

Recent advances in the synthesis and biomedical applications of heterocyclic no-donors

Publication typeJournal Article
Publication date2021-09-21
Journal: Molecules
Quartile SCImago
Q1
Quartile WOS
Q2
Impact factor4.6
ISSN14203049
Organic Chemistry
Drug Discovery
Physical and Theoretical Chemistry
Pharmaceutical Science
Molecular Medicine
Analytical Chemistry
Chemistry (miscellaneous)
Abstract

Nitric oxide (NO) is a key signaling molecule that acts in various physiological processes such as cellular metabolism, vasodilation and transmission of nerve impulses. A wide number of vascular diseases as well as various immune and neurodegenerative disorders were found to be directly associated with a disruption of NO production in living organisms. These issues justify a constant search of novel NO-donors with improved pharmacokinetic profiles and prolonged action. In a series of known structural classes capable of NO release, heterocyclic NO-donors are of special importance due to their increased hydrolytic stability and low toxicity. It is no wonder that synthetic and biochemical investigations of heterocyclic NO-donors have emerged significantly in recent years. In this review, we summarized recent advances in the synthesis, reactivity and biomedical applications of promising heterocyclic NO-donors (furoxans, sydnone imines, pyridazine dioxides, azasydnones). The synthetic potential of each heterocyclic system along with biochemical mechanisms of action are emphasized.

Citations by journals

1
2
3
Russian Chemical Bulletin
Russian Chemical Bulletin, 3, 15%
Russian Chemical Bulletin
3 publications, 15%
MolBank
MolBank, 2, 10%
MolBank
2 publications, 10%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 1, 5%
International Journal of Molecular Sciences
1 publication, 5%
Journal of Molecular Structure
Journal of Molecular Structure, 1, 5%
Journal of Molecular Structure
1 publication, 5%
Angewandte Chemie - International Edition
Angewandte Chemie - International Edition, 1, 5%
Angewandte Chemie - International Edition
1 publication, 5%
Angewandte Chemie
Angewandte Chemie, 1, 5%
Angewandte Chemie
1 publication, 5%
ACS applied materials & interfaces
ACS applied materials & interfaces, 1, 5%
ACS applied materials & interfaces
1 publication, 5%
New Journal of Chemistry
New Journal of Chemistry, 1, 5%
New Journal of Chemistry
1 publication, 5%
Agrochemicals
Agrochemicals, 1, 5%
Agrochemicals
1 publication, 5%
Green Chemistry
Green Chemistry, 1, 5%
Green Chemistry
1 publication, 5%
ACS Omega
ACS Omega, 1, 5%
ACS Omega
1 publication, 5%
Advances in Heterocyclic Chemistry
Advances in Heterocyclic Chemistry, 1, 5%
Advances in Heterocyclic Chemistry
1 publication, 5%
Molecules
Molecules, 1, 5%
Molecules
1 publication, 5%
RSC Medicinal Chemistry
RSC Medicinal Chemistry, 1, 5%
RSC Medicinal Chemistry
1 publication, 5%
Mendeleev Communications
Mendeleev Communications, 1, 5%
Mendeleev Communications
1 publication, 5%
Journal of Organometallic Chemistry
Journal of Organometallic Chemistry, 1, 5%
Journal of Organometallic Chemistry
1 publication, 5%
Stresses
Stresses, 1, 5%
Stresses
1 publication, 5%
1
2
3

Citations by publishers

1
2
3
4
5
6
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 6, 30%
Multidisciplinary Digital Publishing Institute (MDPI)
6 publications, 30%
Elsevier
Elsevier, 4, 20%
Elsevier
4 publications, 20%
Springer Nature
Springer Nature, 3, 15%
Springer Nature
3 publications, 15%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 3, 15%
Royal Society of Chemistry (RSC)
3 publications, 15%
Wiley
Wiley, 2, 10%
Wiley
2 publications, 10%
American Chemical Society (ACS)
American Chemical Society (ACS), 2, 10%
American Chemical Society (ACS)
2 publications, 10%
1
2
3
4
5
6
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Fershtat L. L., Zhilin E. S. Recent advances in the synthesis and biomedical applications of heterocyclic no-donors // Molecules. 2021. Vol. 26. No. 18. p. 5705.
GOST all authors (up to 50) Copy
Fershtat L. L., Zhilin E. S. Recent advances in the synthesis and biomedical applications of heterocyclic no-donors // Molecules. 2021. Vol. 26. No. 18. p. 5705.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.3390/molecules26185705
UR - https://doi.org/10.3390%2Fmolecules26185705
TI - Recent advances in the synthesis and biomedical applications of heterocyclic no-donors
T2 - Molecules
AU - Fershtat, Leonid L
AU - Zhilin, Egor S
PY - 2021
DA - 2021/09/21 00:00:00
PB - Multidisciplinary Digital Publishing Institute (MDPI)
SP - 5705
IS - 18
VL - 26
PMID - 34577175
SN - 1420-3049
ER -
BibTex |
Cite this
BibTex Copy
@article{2021_Fershtat,
author = {Leonid L Fershtat and Egor S Zhilin},
title = {Recent advances in the synthesis and biomedical applications of heterocyclic no-donors},
journal = {Molecules},
year = {2021},
volume = {26},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
month = {sep},
url = {https://doi.org/10.3390%2Fmolecules26185705},
number = {18},
pages = {5705},
doi = {10.3390/molecules26185705}
}
MLA
Cite this
MLA Copy
Fershtat, Leonid L., and Egor S Zhilin. “Recent advances in the synthesis and biomedical applications of heterocyclic no-donors.” Molecules, vol. 26, no. 18, Sep. 2021, p. 5705. https://doi.org/10.3390%2Fmolecules26185705.
Found error?